Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Saffron nasal spray is a botanical therapeutic derived from the active ingredients of the Tibetan medicinal plant *Crocus sativus* (saffron). It is currently being investigated by the People's Hospital of Tibet Autonomous Region as an adjunctive treatment for nasal mucosal inflammatory diseases, including allergic rhinitis and chronic rhinosinusitis. The formulation leverages the anti-inflammatory and antioxidant properties of saffron's active components, such as crocin and safranal, to alleviate symptoms of nasal inflammation. In clinical study settings, it is evaluated alongside guideline-recommended standard treatments to determine its efficacy in product optimization and symptom management.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on saffron nasal spray.